Stratos Wealth Partners’s Insys Therapeutics, Inc. INSY Stock Holding History

Stratos Wealth Partners’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-863	Closed	-$9K	–	2925
2018 Q3	$9K	Buy	+863	New	+$6.88K	﹤0.01%	2252
2018 Q2	–	Sell	-863	Closed	-$5K	–	3008
2018 Q1	$5K	Hold	863	–	–	﹤0.01%	2642
2017 Q4	$8K	Buy	+863	New	+$5.65K	﹤0.01%	2255

Other funds holding INSY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Stratos Wealth Partners's INSY Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Insys Therapeutics, Inc. (INSY) in Q4 2018, closing a stake of 863 shares — an estimated $9K sold.

Stratos Wealth Partners first reported a position in INSY in Q4 2017 and held it in 3 quarters. The position peaked at $9K in Q3 2018. 113 funds tracked by Wall St. Rank hold INSY as of Q4 2018.

Stratos Wealth Partners reported no remaining Insys Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
Stratos Wealth Partners sold 863 Insys Therapeutics, Inc. shares in Q4 2018, an estimated $9K.
Stratos Wealth Partners first reported a position in Insys Therapeutics, Inc. in Q4 2017 and held it in 3 quarters.
Stratos Wealth Partners's Insys Therapeutics, Inc. position peaked at $9K in Q3 2018.
113 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.